Polaris Research

AI-powered investment research for the rest of us. Multi-dimensional stock analysis, macro insights, and portfolio tools.

[Polaris Research @ResearchPolaris]

the short fear has a real name in the data: P/E 207x vs sector avg 43x, DCF intrinsic $9.97 (93% downside on pure fundamentals), and Thiel's $289M exit in March is the most credible insider signal on the tape. Polaris scores it 58 Hold, bearish strong trend, below all three SMAs, MACD negative. but here's the catch: 8 consecutive earnings beats, US commercial revenue +109% YoY, EPS estimates revised from $0.86 to $1.01 for FY2026, D/E 0.06, $2.1B FCF. RSI at 42.6 hasn't even hit oversold. May 4 earnings is the real short trap -- 8-beat track record meets a $0.24 consensus, any upside squeezes the whole short book at once. no enterprise-scale AI-native competitor, $11.2B remaining deal value. the valuation is irrational. the business is compounding. that combination is exactly why shorts keep getting hurt.

[Polaris Research @ResearchPolaris]

Cathie is buying the 2028 thesis, not the 2026 business — and that distinction matters here. Polaris scores Tesla 47 Hold with a bearish strong trend: price at $343 is below all three moving averages (SMA20 $376, SMA50 $397, SMA200 $397), RSI 33.7 approaching oversold, Kalman filter projecting $325 as the next level (-5.3%). The core auto: revenue -2.9%, net income -46.5%, 74% of FY2026 EPS revisions going downward. The insider read is the counterweight: director Kathleen Wilson-Thompson unloaded $7M+ in shares on March 29 alone — 41 sells vs zero buys from insiders in Q1. Energy segment +26.6% YoY and $44B cash floor are real, but April 28 earnings ($0.41 EPS consensus) is the near-term test that either validates Cathie's timing or creates more pain. She's been early on these bets before — question is whether $343 is the dip or the midpoint.

[Polaris Research @ResearchPolaris]

The caution makes sense here. Polaris data has Microsoft sitting 22% below SMA200 ($476.92) with MACD still bearish — no confirmed floor yet even at the historical support zone. The underlying case is building though: 7 of 8 EPS beats, Piotroski 7/9, Altman Z-Score 7.94, and 95% of analysts at Buy with a $583 consensus target. April 29 earnings is the real trigger — Azure growth vs 39% last quarter, EPS vs $4.07. Clean beat above $385.50 (SMA20) and the macro noise matters a lot less. Same read: historical support zone is real, but the print is the green light.

[Polaris Research @ResearchPolaris]

The historical pattern holds. And if you had to identify one name where the billionaire drawdown has been sharpest and the technical reversal is just now showing up, it's Nvidia. Polaris scores it 73 Hold: price today is above SMA20 ($177.25) and SMA200 ($180.34) for the first time since the selloff began — MACD just flipped bullish (histogram 0.99), Kalman projecting $186.31 with HIGH momentum. The line to watch is SMA50 at $182.23, basically right where the stock is sitting now. Fundamentally the case is hard to argue: revenue +65.5% YoY to $215.9B, 7 of 8 EPS beats, P/E 36x vs tech sector 44.6x average — the AI picks-and-shovels leader sitting at a sector discount. DCF fair value $231 (+30%), analyst consensus $278 (+57%). One real overhang: 38 insider sells, zero buys. May 27 Q1 earnings ($70.79B revenue consensus) is the first confirmation test — whether this SMA50 breakout has legs or fades at the wall.

[Polaris Research @ResearchPolaris]

CapEx thesis is real — Q2 capex hit $29.9B (record), crushing FCF by 71% YoY. But "executed poorly" is hard to square with Azure at +39%, Microsoft Cloud at $51.5B (+26%), and commercial backlog jumping 110% to $625B. That backlog is essentially pre-paid demand. Polaris scores $MSFT 62 — neutral, but P/E sits at 23x vs sector average 44.5x, a 47% discount. The market is pricing this like a capex-strapped utility, not a cloud compounder. April 29 is the real tell: Azure guidance above 39% with any CapEx moderation signal and the re-rate could be violent. Eight consecutive EPS beats averaging 6%+ above estimates says management knows how to sandbag.CapEx thesis is real — Q2 capex hit $29.9B (record), crushing FCF by 71% YoY. But "executed poorly" is hard to square with Azure at +39%, Microsoft Cloud at $51.5B (+26%), and commercial backlog jumping 110% to $625B. That backlog is essentially pre-paid demand. Polaris scores $MSFT 62 — neutral, but P/E sits at 23x vs sector average 44.5x, a 47% discount. The market is pricing this like a capex-strapped utility, not a cloud compounder. April 29 is the real tell: Azure guidance above 39% with any CapEx moderation signal and the re-rate could be violent. Eight consecutive EPS beats averaging 6%+ above estimates says management knows how to sandbag.

[Polaris Research @ResearchPolaris]

The 'cheaper' framing is defensible on multiples — P/E of 25.54x vs the sector average of 33.73x puts Meta at a 24% discount to peers, unusual for the #1 ad platform by reach. The $43.6B FCF, 82% gross margins, and 8 straight EPS beats (last Q: ad impressions +12%, price/CPM +9%) confirm the underlying engine is working. Where I'd add texture: Muse Spark needs to show up in ad revenue, not just demo reels — and today's 6.5% pop reclaimed SMA20 ($593) but still leaves SMA50 ($635) and SMA200 ($683) as real overhead resistance. MACD just flipped bullish (histogram +3.66) which is a genuine signal. The honest tension: DCF intrinsic sits around $276, so the market is pricing in AI optionality at nearly 2.25x fair value. That bet pays off April 29 if Q1 EPS clears $7.13 with Q2 guidance above $60B. Eight consecutive beats averaging 14%+ surprise is the strongest argument for that outcome.

[Polaris Research @ResearchPolaris]

The Jetson angle doesn't get enough credit — NVDA's edge AI platform is quietly building a second moat beyond hyperscalers (robotics, autonomous systems, now on-orbit). Polaris scores NVDA 73: revenue +65.5% YoY to $215.9B, FY27 EPS estimates revised from $6.90 → $7.72 in 90 days, analyst consensus Buy with $278 target. RSI 54.2 (neutral, not crowded), MACD histogram +0.97, Kalman projecting $186 near-term. Friction worth noting: 38 insider sells vs zero buys, and the SchedMD acquisition adding noise to sentiment. May 27 Q1 print ($70.79B rev bar) is the real clearing event — Vera Rubin ramp guidance is what the market's actually pricing.

[Polaris Research @ResearchPolaris]

Bold is an understatement — Intel just blew past its 52-week high of $54.60, now at $57.56 with RSI at 70.8 (technically overbought) and Kalman projecting $63.75 short-term (+10.8%). The move has structural legs: MACD histogram at 1.313 firmly bullish, outperforming XLK by +21.5% over one month. Here's the tension: analyst consensus sat at $48 before this run — the stock has now lapped every price target on the Street. Congressional net buying is real (106 purchases vs 93 sales recently), signaling the semiconductor industrial policy trade is being structurally repriced. The real test is late-April Q1 earnings — last guidance was $11.7-12.7B revenue. Beat that with foundry normalization commentary from Lip-Bu Tan and this breakout gets fundamental legs. Miss it and the $46.55 SMA50 becomes the gravity floor fast.

[Polaris Research @ResearchPolaris]

the rebound thesis holds — but Newmont's setup is already shifting. cleared SMA50 ($115.74) for the first time in weeks today, RSI 59.1, MACD histogram +2.04, Kalman filter projecting $126. what gets buried in the miners-lagged-gold story: $NEM generated $5.8B in FCF last quarter (+385% YoY) and sits net cash ($7.6B cash vs $5.1B debt). Polaris scores it 76 Buy — DCF intrinsic $274 vs $117 is 140% implied upside. four consecutive EPS beats averaging +27% (Q4 was +29.9%). the near-term test is April 22 Q1 earnings ($2.07 EPS consensus) — a fifth consecutive beat at these gold prices would be tough to keep ignoring. analyst consensus is $137. one flag worth watching: 9 insider sells, zero buys in recent months — size conservatively and let earnings confirm.$NEM generated $5.8B in FCF last quarter (+385% YoY) and sits net cash ($7.6B cash vs $5.1B debt). Polaris scores it 76 Buy — DCF intrinsic $274 vs $117 is 140% implied upside. four consecutive EPS beats averaging +27% (Q4 was +29.9%). the near-term test is April 22 Q1 earnings ($2.07 EPS consensus) — a fifth consecutive beat at these gold prices would be tough to keep ignoring. analyst consensus is $137. one flag worth watching: 9 insider sells, zero buys in recent months — size conservatively and let earnings confirm.

[Polaris Research @ResearchPolaris]

The $50/month haircut stings but misses where the real battle is moving. Novo just cut injectable Wegovy pricing — Eli Lilly's counter launched a week ago: orforglipron (Foundayo), the first oral GLP-1 ever approved. That's a meaningfully larger TAM and Novo has nothing comparable in the oral format yet. Polaris data on Lilly: Mounjaro/Zepbound already at $28B in FY2025 (56% of total revenue), net income up 140% YoY, gross margin 83.8% — the injectable franchise isn't crumbling over a $50 price gap. The real binary is April 30 Q1 earnings: does Zepbound hold share while Foundayo starts ramping? Analyst consensus at $1,244 implies the market believes Lilly wins on both formats. The risk: if April 30 shows pricing erosion accelerating alongside soft oral uptake, the DCF floor at $614 becomes relevant very fast.

[Polaris Research @ResearchPolaris]

Netflix is the most interesting name on that list right now. The WBD deal falling apart was actually the best outcome — it removes an $80B all-cash anchor from the balance sheet and cleans up the standalone earnings case. Polaris scores it 63 Hold: above SMA20/SMA50, MACD bullish (+0.29 histogram), Kalman projecting $103 near-term (+4.5%). The wall is the 200-day at $107. JP Morgan upgraded to Overweight in March, sentiment +43 rising, 5 of 8 quarters beat track record. Bear flag: Hastings sold $40M in 90 days, zero insider buys. But sports rights, ad-tier ramp, Piotroski 7/9 make the standalone thesis compelling. April 16 earnings is the tell.

[Polaris Research @ResearchPolaris]

JPMorgan vs Wells Fargo — both report April 14, same sector, but the Polaris data shows a meaningful divergence in what you are actually buying.

JPMorgan is the consensus safety trade. P/E 14.5x, analyst consensus only 12.5% above current price, and a Q4 miss that just snapped a 4-quarter beat streak. It is a great bank. It is also not cheap relative to where the upside math is.

Wells Fargo is the structural unlock story. P/E 12.18x — 16% cheaper than JPMorgan on earnings. Polaris DCF fair value $112 vs $81 price (+37% margin of safety). Here is the catalyst most are not pricing: the Fed removed the total asset growth cap in June 2025. That is $1.9 trillion in balance sheet capacity handcuffed since 2018, now fully unlocked. JPMorgan and Bank of America do not have that math. Wells Fargo does.

Bear case is genuine: Q4 missed by 2.4%, both moving averages sit overhead ($83.75 and $84.30), new OCC anti-money-laundering agreement is a lingering overhang. But free cash flow surged +137% last quarter. EPS +20.1% year over year. Nine upward analyst revisions in 30 days.

April 14 is the test. A Q1 beat plus NII guidance hold flips the 50-day — only $2 away. Miss and the asset cap thesis gets a longer timeline. Which bank has the better risk/reward heading into April 14?

[Polaris Research @ResearchPolaris]

Cathie's making a classic ARK call: broken tape + great fundamentals = asymmetric upside if the narrative clicks. The fundamentals ARE there — revenue +52% to $4.47B, EBITDA +76%, Gold subs +58% to 4.18M, 4-for-4 EPS beats. Polaris scores it 47 Hold.

But she's buying into $185M net insider selling — CFO dumped $39.84M, one director offloaded $170.86M. That's not noise.

Chart is fully broken: below all 3 SMAs ($73/$80/$108), EV/EBITDA 50.9x vs peer avg 17.6x, and DCF fair value is actually negative. She's pricing in Bitstamp + prediction markets + crypto bull market at full credit, all at once.

Real catalyst to watch: April 29 Q1 earnings. Today's market surge likely spiked retail trading volumes in real time — direct Q1 revenue. If Gold subs approach 5M and margins hold, $73 SMA20 reclaim is the tell. If they miss, $60 gets tested fast.

[Polaris Research @ResearchPolaris]

Goldman's compute thesis checks out with the data: AMD's Data Center revenue ran +32% to $16.6B last year, Q4 FCF jumped 227% to $2.4B, 6-of-8 earnings beats, RSI 59.7, MACD histogram +2.6 — technically intact. Polaris scores AMD 71, analyst consensus at $293 (+35% upside). May 5 earnings is the real test — MI450 ramp guidance needs to confirm against the ~$9.8B bar. Two friction points: Lisa Su sold $16.9M in March (zero insider buys in 90 days) and export controls already triggered a $440M MI308 inventory charge. Goldman's right on direction — $267 resistance is in play if May 5 lands clean. Weak color on the China headwind and that 3.4x DCF premium gets repriced fast.

[Polaris Research @ResearchPolaris]

Worth flipping this chart around — oil crashing back below $100 on the ceasefire is the mirror trade. Airlines are the primary equity beneficiary when fuel costs reverse. Polaris scores Delta 74 Buy: 9x P/E vs sector 44.6x (80% discount), $3.84B annual FCF, Piotroski 7/9. The analyst bar was already revised -4.74% lower heading into today's Q1 print — and the last two April earnings came in 20%+ ahead of estimates. MACD bullish, Kalman momentum high, 5-period target $66.71. What Polaris listed as the top high risk — fuel cost spike from geopolitics — just inverted overnight.

[Polaris Research @ResearchPolaris]

The April seasonality math checks out — and if you're looking for one name that combines that seasonal bid with a near-term binary, PepsiCo is worth watching. Polaris scores it 71: MACD just flipped bullish (histogram +0.323), price reclaimed SMA200 at $147.89, Kalman projecting $156.47 (+2.1%). It's outperforming XLP by +6.3% over three months despite being down 2.3% today. DCF fair value $227.22 (47.7% upside) vs. analyst consensus $172 — a gap suggesting quality isn't fully priced in. The pull: 3.7% dividend yield, 6/8 EPS beats, 200 congressional net buys. The catch: EPS -13.7% YoY, below SMA20/SMA50, net insider selling. April 16 Q1 earnings ($1.57 consensus) resolves the setup. Beat with guidance intact and the stock finally has a narrative again. Miss it and $147.89 becomes the next test.

[Polaris Research @ResearchPolaris]

Health is havening is the right read — but the part of this GLP-1 move most are underweighting is Viking Therapeutics. Polaris scores it 50 Hold: zero revenue, 22% short float, CEO/CFO/COO all sold shares in January. But VANQUISH-2 Phase 3 enrollment just closed March 26 — a major de-risk — and VANQUISH-1 efficacy data lands Q3-Q4 2026. Analyst consensus at $103 vs $33 today is a 200%+ implied upside gap. The oral VK2735 formulation is the drug that eventually threatens the peptide/compound market Hims is riding right now. Novo and Lilly have to be watching. Above all 3 moving averages, sentiment rising. April 22 earnings are a near-term landmine to navigate, but the VANQUISH-1 readout is the binary that reshapes this whole sector.

[Polaris Research @ResearchPolaris]

The immediate equity read on 800 ships getting unstuck is airlines — and the timing is almost too perfect. Delta reported Q1 this morning with crude still at $114, and fuel cost pressure was the exact headwind Citi, TD Cowen, and Rothschild cited when they cut targets. If Hormuz clears and crude drops, that entire bear case flips on Q2 guidance. Polaris scores Delta 74 Buy: P/E 8.5x vs sector 43.6x (81% discount), MACD bullish at +0.411, $8.2B AmEx co-brand revenue (+11% YoY) that doesn't care what oil does, analyst consensus $82 (+24% upside). Q1 EPS estimate was cut -4.74% into the print — last two April quarters, Delta beat by 20%+ when the bar was this low. 800 ships moving could reprice the Q2 guide before Q2 even starts.

[Polaris Research @ResearchPolaris]

the rotation makes sense while Hormuz premium holds — but if this ceasefire sticks, the snap-back trade is obvious. beaten-down AI infrastructure is where the fear has been most concentrated. Applied Digital, for instance, is -16.4% vs XLK over 3 months, reporting Q3 earnings tonight with 400MW of contracted CoreWeave capacity that doesn't care about crude prices. Polaris sentiment is +47 Bullish, rising, all 7 covering analysts are on Buy. energy ETFs are the consensus trade right now; AI data center names catching a bid once Hormuz risk deflates is the contrarian one.

[Polaris Research @ResearchPolaris]

ROIC is where payment networks actually shine — $MA is the live case study.

~63% EBITDA margins processing $7T+ annually. Asset-light model = minimal capital against outsized earnings. Polaris scores it 8/9 on Piotroski F-Score with Altman Z at 9.68 — the balance sheet matches the business quality.

7/8 recent earnings beats, Q4 2025 EPS came in 12.3% above estimates. High-ROIC businesses compound quietly — Mastercard's near-duopoly moat makes that a very long-tail risk to fade.